The report "Contrast
Injector Market by
Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector
Head, Tubing), Accessories), & Application (Radiology, Interventional
Cardiology, Interventional Radiology) - Global Forecast to 2021", analyzes and studies the major market drivers,
restraints/challenges, and opportunities.
This
report studies the global contrast injectormarket for the forecast period of
2016 to 2021. This market is expected to reach USD 636.1 Million by 2021 from
USD 445.5 Million in 2016, growing at a CAGR of 7.4%.
The contrast injector market growth can primarily be
attributed to factors such as the large number of approvals for contrast agents
in different geographies and increasing number of public and private diagnostic
centers. On the other hand, the side effects and allergic reactions associated
with contrast agents are expected to limit the market growth to a certain
extent. In the coming years, the contrast media injector market is expected to
witness the highest growth rate in the Asia-Pacific region. The high growth in
the region can be attributed to the rising approvals for various contrast
agents in Asia-Pacific countries, developing markets, and the growing presence
of international players in this region. In addition, the availability of
government support for research, high healthcare expenditures in APAC
countries, rising aging population, and increasing cancer incidences are
expected to support the growth of the Asia-Pacific contrast injector market.
The
global contrast injector market is segmented on the basis of product,
application, and region.
On the
basis of product, the contrast injector market is categorized into injector
systems, consumables, and accessories. In 2016, the consumables segment is
estimated to account for the largest share of the contrast injector market.
This growth is mainly attributed to the recurring use of consumables in
diagnostic procedures to maintain hygienic conditions. The injector systems
segment is further divided into CT injector systems, MRI injector systems, and
angiography injector systems. In 2016, the CT injector systems segment is
expected to command the largest share of the market. The MRI injector systems
segment is expected to grow at the highest CAGR during the forecast period. The
consumables segment is further divided into injector heads, syringes, tubing,
and other consumables (scan bags, valves, vials, and spikes). In 2016, the
injector heads segment is estimated to account for the largest share of the
consumables market. The injector heads segment is further categorized into
single head injectors, dual head injectors, and syringeless injectors. The
single head injectors segment is expected to command the largest share of the
market, in 2016. The syringeless injectors segment is projected to grow at the
highest CAGR during the forecast period.
On the
basis of application, the contrast media injector market is segmented into
radiology, interventional cardiology, and interventional radiology. In 2016,
the radiology segment is estimated to command the largest share of the contrast
injector market. The interventional cardiology segment is expected to grow at
the highest CAGR during the forecast period.
Key players in the global contrast injector market include Bracco
Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France),
Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.),
AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device
Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd.
(China).
Contact:
Mr.
Shelly Singh
MarketsandMarkets™
INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441newsletter@marketsandmarkets.com
No comments:
Post a Comment